Biopreservation Market To 2023 High Growth Opportunities, Emerging Trends, Market Review, Global Forecast 2030

Biopreservation Market Growth & Trends

The biopreservation market is projected to register a robust CAGR of around 15% during the forecast period, driven by the expanding applications of personalized medicine, cell-based therapies, and the increasing establishment of biobanks and tissue repositories worldwide. Rising R&D spending in biotechnology and life sciences is further supporting market expansion. However, factors such as high equipment costs and the stringent regulatory framework governing biospecimen storage may act as growth restraints.

Get Free Sample Report: https://meditechinsights.com/biopreservation-market/request-sample/

What is Biopreservation?

Biopreservation refers to the process of preserving biological materials such as cells, tissues, blood, and organs under controlled cryogenic conditions to maintain their structural and functional integrity. The technique uses cryoprotective agents (CPAs) to prevent ice crystal formation, thereby safeguarding cell viability during freezing and thawing cycles. This preservation approach plays a pivotal role in biobanking, regenerative medicine, and the long-term storage of biospecimens used in research and clinical applications.

Rising Demand for Regenerative and Stem Cell Therapies Boosts Market Growth

The growing focus on regenerative medicine and advanced cellular therapies—including stem cell treatments, gene editing, and tissue engineering—is a key catalyst for the biopreservation industry. These therapies depend on the ability to maintain biological samples in optimal condition over extended periods.With the increasing use of stem cells to address chronic diseases such as diabetes, cardiovascular disorders, and Parkinson’s disease, demand for reliable preservation systems has surged. In addition, the growing number of clinical trials and biotech research initiatives has accelerated investments in cold chain infrastructure and standardized biobanking protocols.

For instance, in April 2024, Thermo Fisher Scientific launched its ENERGY STAR® certified TSX Universal Series ultra-low temperature (ULT) freezers, designed to deliver improved temperature control, faster recovery, and greater energy efficiency—supporting laboratories focused on both performance and sustainability.

Vitrification Gains Momentum for Enhanced Post-Thaw Viability

Recent innovations have reshaped the biopreservation landscape, particularly through the adoption of vitrification—a rapid freezing process that converts biological materials into a glass-like, solid state without ice crystal formation. This method employs high concentrations of cryoprotectants and ultra-rapid cooling, proving especially effective for sensitive samples such as oocytes, embryos, and stem cells, which are vulnerable to damage under conventional slow-freezing techniques.

Vitrification’s superior post-thaw survival rates and ability to preserve cell structure have expanded its use across organ transplantation, regenerative research, and fertility preservation. The technology’s precision and reproducibility make it increasingly indispensable in both clinical and research environments, reinforcing its role in advancing modern biopreservation practices.

Competitive Landscape

The global biopreservation market is characterized by strong competition, with participation from leading and emerging players including:Azenta US, Inc.; Biomatrica, Inc. (Exact Sciences Corporation); BioLife Solutions; MVE Biological Solutions; Taylor-Wharton; Thermo Fisher Scientific, Inc.; LabVantage Solutions, Inc.; X-Therma Inc.; PrincetonCryo; Panasonic Healthcare Holdings Co., Ltd.; and Stirling Ultracold, among others.

Market leaders are actively pursuing product innovations, strategic partnerships, and geographical expansion to strengthen their global presence and meet the growing demand for efficient, sustainable biopreservation systems.

key Request a free sample copy or view report summary: https://meditechinsights.com/biopreservation-market/request-sample/

Table of content:

1.      Research Methodology​

o    Secondary Research​

o    Primary Research​

o    Market Estimation​

§  Bottom-Up Approach​

§  Top-Down Approach​

o    Market Forecasting​

2.      Executive Summary

o    Biopreservation Market Snapshot (2025-2030)​

o    Segment Overview​

o    Regional Snapshot​

o    Competitive Insights ​

3. Global Biopreservation Market Size & Forecast (2023-2030), By Biospecimen, USD Million

   • Introduction​

   • Tissue

   • Organs

   • Stem cells

   • Others

4. Global Biopreservation Market Size & Forecast (2023-2030), By Application, USD Million

   • Introduction​

   • Therapeutics

   • Research

5. Global Biopreservation Market Size & Forecast (2023-2030), By End-user, USD Million

   • Introduction​

   • Biobanks

   • Hospitals

   • Gene Banks

   • Others

About Us:

At Medi-Tech Insights, we are a global healthcare consulting firm committed to delivering premium insights and strategic solutions to help our clients navigate the complex and evolving healthcare landscape.

Our team combines deep industry expertise with data-driven market intelligence to provide actionable insights that enable smarter decisions and sustainable success.

With a strong focus on innovation, quality, and impact, Medi-Tech Insights has become a trusted partner for leading healthcare investors and corporates across the globe.